[go: up one dir, main page]

ATE126594T1 - Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen. - Google Patents

Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.

Info

Publication number
ATE126594T1
ATE126594T1 AT89904881T AT89904881T ATE126594T1 AT E126594 T1 ATE126594 T1 AT E126594T1 AT 89904881 T AT89904881 T AT 89904881T AT 89904881 T AT89904881 T AT 89904881T AT E126594 T1 ATE126594 T1 AT E126594T1
Authority
AT
Austria
Prior art keywords
campylobacter pylori
molecular weight
high molecular
producing
weight cell
Prior art date
Application number
AT89904881T
Other languages
English (en)
Inventor
Dolores G Evans
Doyle J Evans
David Y Graham
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Application granted granted Critical
Publication of ATE126594T1 publication Critical patent/ATE126594T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT89904881T 1988-03-10 1989-03-09 Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen. ATE126594T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/166,138 US4882271A (en) 1988-03-10 1988-03-10 Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection

Publications (1)

Publication Number Publication Date
ATE126594T1 true ATE126594T1 (de) 1995-09-15

Family

ID=22601983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89904881T ATE126594T1 (de) 1988-03-10 1989-03-09 Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.

Country Status (8)

Country Link
US (1) US4882271A (de)
EP (1) EP0439462B1 (de)
JP (1) JP2901296B2 (de)
AT (1) ATE126594T1 (de)
AU (1) AU614608B2 (de)
CA (1) CA1339068C (de)
DE (1) DE68923882T2 (de)
WO (1) WO1989008843A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
FR2637612B1 (fr) * 1988-10-06 1993-09-10 Pasteur Institut Sequences de nucleotides codant pour une proteine a activite ureasique
US5234910A (en) * 1989-07-18 1993-08-10 University Hospital Acid inhibitor of bacterial origin
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
US5262156A (en) * 1991-08-12 1993-11-16 Hycor Biomedical, Inc. Antigenic compositions and their use for the detection of Helicobacter pylori
US5859219A (en) * 1992-02-26 1999-01-12 Vanderbilt University Purified vacuolating toxin from Helicobacter pylori and methods to use same
JP3920320B2 (ja) * 1992-02-26 2007-05-30 ヴァンダービルト ユニバーシティ 精製されたＨｅｌｉｃｏｂａｃｔｅｒ ｐｙｌｏｒｉ由来の空胞形成毒素およびその使用方法
US6130059A (en) * 1992-03-02 2000-10-10 Covacci; Antonello Helicobacter pylori proteins useful for vaccines and diagnostics
US7141244B1 (en) 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
EP0967279B1 (de) * 1992-03-02 2008-01-02 Novartis Vaccines and Diagnostics S.r.l. Helicobacter pylori Cytotoxin verwendbar in Impfstoffe und Diagnostik
IT1262895B (it) * 1992-03-02 1996-07-22 Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
CA2067603A1 (en) * 1992-04-29 1993-10-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
AU687002B2 (en) * 1992-04-29 1998-02-19 Auspharm International Limited In vitro test for helicobacter pylori
US5420014A (en) * 1992-04-30 1995-05-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
DE4220653A1 (de) * 1992-06-26 1994-01-13 Boehringer Mannheim Gmbh Verfahren und Mittel zum Nachweis eines Analyten enthaltend glykosidische Tenside
GB9313437D0 (en) * 1993-06-30 1993-08-11 Smith Andrew W Pathogenicity sequences in helicobacter pylori
JPH09502604A (ja) * 1993-08-27 1997-03-18 エンテリック リサーチ ラボラトリーズ インコーポレイテッド Ｃａｍｐｙｌｏｂａｃｔｅｒｊｅｊｕｎｉ抗原、並びにそれらの製造及び利用
US5780040A (en) * 1994-06-08 1998-07-14 Tufts University School Of Medicine Hospital, Inc. Helicobacter pylori nickel binding protein
GB2290866B (en) * 1994-06-29 1998-10-07 Reckitt & Colmann Prod Ltd Detection of Helicobacter pylori infection using antibodies to carbonic anhydrase
EP0769018B1 (de) * 1994-07-01 2002-12-18 Chiron Corporation Helicobacter proteine und impstoffe
EP0797585A1 (de) * 1995-10-09 1997-10-01 Pasteur Merieux Serums Et Vaccins Lactoferrin rezeptor von helicobacter
WO1997025429A1 (en) * 1996-01-04 1997-07-17 Rican Limited Helicobacter pylori bacterioferritin
US5932430A (en) * 1996-05-09 1999-08-03 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US5716791A (en) * 1996-05-09 1998-02-10 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US5942409A (en) * 1998-07-31 1999-08-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for identification of substances modulating ureI dependent mechanisms of Helicobacter pylori metabolism
US20050175629A1 (en) * 2001-08-31 2005-08-11 Giuseppe Del Giudice Helicobacter pylori vaccination

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172690B1 (da) * 1981-10-22 1999-05-31 Tanabe Seiyaku Co Analogifremgangsmåde til fremstilling af salte af sulfodehydroabietinsyre eller hydrater deraf
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US4785086A (en) * 1985-01-17 1988-11-15 Integrated Genetics, Inc. Test for Campylobacter
CA1274757A (en) * 1985-05-17 1990-10-02 Barry James Marshall Compositions and methods for the detection of urease for the diagnosis of campylobacter pyloridis infection
US4748113A (en) * 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
WO1987001119A1 (en) * 1985-08-16 1987-02-26 Gregory Murray Winn Monoclonal antibodies reactive against campylobacter pyloridis

Also Published As

Publication number Publication date
AU614608B2 (en) 1991-09-05
WO1989008843A1 (en) 1989-09-21
US4882271A (en) 1989-11-21
EP0439462A1 (de) 1991-08-07
AU3427289A (en) 1989-10-05
CA1339068C (en) 1997-07-29
EP0439462B1 (de) 1995-08-16
EP0439462A4 (de) 1991-06-10
DE68923882T2 (de) 1996-03-14
DE68923882D1 (de) 1995-09-21
JP2901296B2 (ja) 1999-06-07
JPH03504412A (ja) 1991-09-26

Similar Documents

Publication Publication Date Title
ATE126594T1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
NO870412L (no) Peptider.
DE69126248D1 (de) Immunchromatographischer assay und verfahren zur nutzung desselben
ATE114672T1 (de) Peptidzusammensetzung und verfahren zum nachweis von antikörpern gegen htlv-iii.
ATE141286T1 (de) Hiv-peptide, künstliche hiv-antigene und immuntestsätze
NO913186L (no) Fremgangsmaate for anvendelse og syntese av peptider.
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
ATE130681T1 (de) Bestimmung eines felinen pathogen-specifischen antikörpers und eines felinen pathogenen antigens in einem immuntest.
DE69030124D1 (de) Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus
DE68925899D1 (de) Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen
NO881151L (no) Syntetisk hiv-1-antigen.
DE59008779D1 (de) Verfahren zur Bestimmung von HIV-Antikörpern.
ATE142789T1 (de) Träger zur bindung von antiphospholipid- antikörpern, diese antikörper verwendender immunotest und kit dafür
ATE123072T1 (de) Testsystem zum nachweis von antikörpern und methode zur herstellung nichtmenschlicher immunantikörper.
DE69114339D1 (de) Verfahren zur Identifizierung oder Bestimmung von Proteinen und Verwendungen dazu.
ATE2699T1 (de) Serologisches verfahren zum nachweis von neisseria gonorrhoeae antikoerpern im menschlichen serum, ein dazu angewendetes speziesspezifisches waermestabiles antigen und verfahren zur herstellung dieses antigens.
SE8902148D0 (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
KR880014376A (ko) Hiv 특이 항원 영역의 모노클로날 항체 및 그 용법
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
DE3686717D1 (de) Immuntestverfahren.
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
ATE122150T1 (de) Einschritt-immuntest zur bestimmung von antigen- spezifischen antikörpern aller immunglobulin- klassen und dazu geeignetes mittel.
DK142488D0 (da) Treponema hyodysenteriae antigener, vaccine indeholdende disse antigener eller fragmenter deraf og metode til bestemmelse af antistoffer over for treponema hyodysenteriae